Indian
India aims at making automobile industry number one in the world,Gadkari
Ntin Gadkari, Union Minister of Road Transport and Highways ,...
WHO approval for Covaxin to significantly ease travel for vaccinated Indians, says External Affairs Ministry
.. Ministry of External Affairs (MEA) Spokesperson Arindam Bagchi...
No pre or post-arrival Covid testing for kids, say revised guidelines for international arrivals
According to the existing guidelines, if travelers are fully...
Covaxin safe, shows 77.8 per cent efficacy against symptomatic COVID-19: Lancet study
Covaxin, an inactivated whole virus vaccine developed by...
International
Forced payouts of Pandemic claims risk insurers’ financial stability: Regulators
Disputes over cover for businesses struggling to stay afloat during coronavirus lockdowns have erupted in countries including Britain and the United States, where eight states have brought in laws which would require insurers to pay claims, mainly to small businesses, despite exclusions.
Where pandemic risks are covered by a policy, insurers should pay out such claims in a prompt and efficient manner, the International Association of Insurance Supervisors (IAIS) said, while cautioning “against initiatives seeking to require insurers to retroactively cover COVID-19 related losses.”
RMS unveils high definition models for European severe convective storm
“The multi-peril stochastic set includes over 7.5 million events, covering 17 countries, based on 50,000 years of simulations, so that we appropriately capture the spatial and temporal scale of convective storm risk in the European modelling domain,” said Mohsen Rahnama, chief risk modeling officer, RMS, said.
Recent events have shown the potential cost of this peril for the re/insurance industry, said RMS, noting that from 2013 to 2019, losses from major and attritional severe convective storms in Europe exceeded €12 billion (US$13 billion),said RMS in a statement.
“Businesses need to restart facilities with care and caution after coronavirus lockdown”:AGCS
Gilead in talks to expand global supply of COVID-19 drug remdesivir
Briefs
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Events
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Advertisement
Articles
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Features
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Data
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Interviews
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Facts
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
